Neuromedin U Alters Bioenergetics and Expands the Cancer Stem Cell Phenotype in HER2-positive Breast Cancer

International Journal of Cancer - United States
doi 10.1002/ijc.30705
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

HER2 Regulates Cancer Stem-Like Cell Phenotype in ALK Translocated NSCLC

International Journal of Oncology
Cancer ResearchOncology
2017English

A Novel HER2-positive Breast Cancer Phenotype Arising From Germline TP53 Mutations

Journal of Medical Genetics
Genetics
2010English

miR-375 Inhibits Cancer Stem Cell Phenotype and Tamoxifen Resistance by Degrading HOXB3 in Human ER-positive Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2017English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

New Developments in the Treatment of HER2-positive Breast Cancer

Breast Cancer: Targets and Therapy
Oncology
2012English

Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer

Oncotarget
Oncology
2017English

NF-kappaΒ-inducing Kinase Regulates Stem Cell Phenotype in Breast Cancer

Scientific Reports
Multidisciplinary
2016English

Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer

Scientific Reports
Multidisciplinary
2017English

Oncofertility Counselling in Premenopausal Women With HER2-positive Breast Cancer

Oncotarget
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy